n(6)-carboxymethyllysine has been researched along with Pancreatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bengtsson, E; Blixt, O; Danielsson, L; Jansson, B; Nodin, B; Nordin Fredrikson, G; Persson, N; Risinger, C; Welinder, C; Wendel, U | 1 |
| Blasetti Fantauzzi, C; Cappello, P; de Latouliere, L; Iacobini, C; Ionta, V; Manni, I; Menini, S; Novelli, F; Pesce, C; Piaggio, G; Pugliese, G | 1 |
| Chen, L; Cross, AJ; Duan, Z; Hollenbeck, A; Jiao, L; Kahle, L; Risch, A; Sinha, R; Stolzenberg-Solomon, R; Striker, G; Subar, AF; Vlassara, H; Zimmerman, TP | 1 |
| Allen, NE; Argüelles Suárez, MV; Barricarte, A; Boeing, H; Boutron-Ruault, MC; Bueno-de-Mesquita, HB; Clavel-Chapelon, F; Crowe, FL; Dorronsoro, M; Drogan, D; Duell, EJ; Fedirko, V; Grote, VA; Huerta Castaño, JM; Jenab, M; Jeurnink, SM; Kaaks, R; Khaw, KT; Lagiou, P; Lindkvist, B; Lukanova, A; Mattiello, A; Nielsen, MR; Nieters, A; Overvad, K; Palli, D; Peeters, PH; Racine, A; Regner, S; Rohrmann, S; Romaguera, D; Roswall, N; Sánchez, MJ; Siddiq, A; Sieri, S; Sund, M; Teucher, B; Tjønneland, A; Trichopoulos, D; Trichopoulou, A; Tumino, R; Vineis, P; Wareham, N; Ye, W | 1 |
1 trial(s) available for n(6)-carboxymethyllysine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.
Topics: Aged; Cohort Studies; Databases, Factual; Diet; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Lysine; Male; Meat; Middle Aged; Normal Distribution; Pancreatic Neoplasms; Proportional Hazards Models; Prospective Studies; Risk; Sex Factors; Surveys and Questionnaires; United States | 2015 |
3 other study(ies) available for n(6)-carboxymethyllysine and Pancreatic Neoplasms
| Article | Year |
|---|---|
A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.
Topics: Animals; Antibodies, Monoclonal; Atherosclerosis; Epitope Mapping; Female; Glycation End Products, Advanced; Humans; Lysine; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Protein Array Analysis | 2018 |
The advanced glycation end-product N
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Diabetes Complications; Disease Models, Animal; Disease Progression; Genes, ras; Humans; Lysine; Mice, Inbred C57BL; Mice, Transgenic; Pancreatic Neoplasms; Peptides; Receptor for Advanced Glycation End Products; Risk Factors; Signal Transduction; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2018 |
The associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC Cohort.
Topics: Adult; Aged; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Pancreatic Neoplasms; Prognosis; Prospective Studies; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2012 |